<DOC>
	<DOCNO>NCT02773667</DOCNO>
	<brief_summary>Correlation analysis estimate renal function biological half life 131-I radioiodine treatment patient differentiate thyroid cancer .</brief_summary>
	<brief_title>Renal Tracer Elimination Thyroid Cancer Patients Treated With 131-Iodine</brief_title>
	<detailed_description>131-I radioiodine treatment patient differentiate thyroid cancer mainly renally excrete . It advise clinical guideline serum creatinine determine apply 131-I necessary administer dose reduce . Nevertheless guideline give advice extent dose decrease . The adjustment discretion attend physician . Aim prospective study correlate biological half life 131-I renal function give objective recommendation concern reduction apply dose patient limited renal function .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>patient differentiate thyroid carcinoma stationary treatment diagnostic radioiodine state thyroidectomy write consent patient minimum age 18 year write consent patient patient large residual thyroid tissue ( iodine uptake &gt; 10 % ) child 18 year age inclusion concurrent interventional study patient without TSHstimulation rhTSH</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>